Table 3.
Males and females combined
|
Females
|
Males
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Cancer | ICD-9 code | Obs | SIR | 95% CI | Obs | SIR | 95% CI | Obs | SIR | 95% CI |
All cancers | 304 | 0.95 | 0.83–1.05 | 142 | 0.86 | 0.72–1.01 | 162 | 1.02 | 0.87–1.18 | |
Digestive organs and peritoneum | 150–159 | 69 | 1.03 | 0.80–1.30 | 33 | 1.09 | 0.75–1.52 | 36 | 0.98 | 0.69–1.36 |
Stomach | 151 | 7 | 1.08 | 0.44–2.23 | 2 | 0.88 | 0.11–3.20 | 5 | 1.19 | 0.39–2.78 |
Colon | 153 | 26 | 0.88 | 0.58–1.30 | 14 | 0.96 | 0.52–1.61 | 12 | 0.81 | 0.42–1.42 |
Rectum | 154 | 17 | 1.28 | 0.74–2.04 | 9 | 1.57 | 0.72–2.98 | 8 | 1.06 | 0.46–2.08 |
Respiratory and intrathoracic organs | 160–165 | 62 | 1.07 | 0.82–1.37 | 19 | 0.87 | 0.53–1.37 | 43 | 1.18 | 0.86–1.59 |
Trachea, bronchus, and lung | 162 | 57 | 1.10 | 0.83–1.42 | 19 | 0.94 | 0.57–1.47 | 38 | 1.20 | 0.85–1.64 |
Bone, connective tissue, skin, breast | 170–175 | 50 | 0.80 | 0.59–1.06 | 47 | 0.84 | 0.61–1.11 | 3 | 0.49 | 0.10–1.43 |
Breast (female only) | 174 | 42 | 0.82 | 0.59–1.10 | 42 | 0.82 | 0.59–1.10 | |||
Genitourinary organs | 179–189 | 82 | 0.78 | 0.77–1.22 | 26 | 0.81 | 0.53–1.18 | 56 | 1.09 | 0.82–1.41 |
Body of the uterus (female only) | 182 | 5 | 0.50 | 0.16–1.16 | 5 | 0.50 | 0.16–1.16 | |||
Ovary (female only) | 183 | 9 | 1.14 | 0.52–2.16 | 9 | 1.14 | 0.52–2.16 | |||
Prostate (male only) | 185 | 29 | 0.91 | 0.61–1.30 | 29 | 0.91 | 0.61–1.30 | |||
Bladder | 188 | 23 | 1.44 | 0.91–2.16 | 7 | 1.68 | 0.67–3.46 | 16 | 1.36 | 0.78–2.20 |
Kidney | 189 | 12 | 1.48 | 0.76–2.58 | 4 | 1.30 | 0.35–3.32 | 8 | 1.59 | 0.69–3.13 |
Other and unspecified sites | 190–199 | 18 | 0.94 | 0.56–1.49 | 10 | 0.98 | 0.47–1.81 | 8 | 0.90 | 0.39–1.76 |
Lymphatic and hematopoietic tissue | 200–208 | 19 | 0.71 | 0.43–1.12 | 7 | 0.58 | 0.23–1.20 | 12 | 0.82 | 0.42–1.43 |
Obs, observed cases. Results are shown only for cancer subgroups that have > 10 observed cases or that have > 5 observed cases and SIRs > 1.00 for at least one comparison.